U.S. minorities less likely to get colon cancer screening

January 15, 2013
U.S. minorities less likely to get colon cancer screening: study
Researcher says reasons include high cost, lower health literacy, lack of doctors.

(HealthDay)—Minority patients in the United States are less likely than whites to be screened for colorectal cancer, a new study finds.

Researchers analyzed national data from between 2000 and 2005 and found that 42 percent of whites were screened for colorectal cancer, compared with 36 percent of blacks, 31 percent of Asians and Native Americans and 28 percent of Hispanics.

Although it is widely believed that lack of access and money are the main barriers to getting screenings, this study found that other factors play a role in the lower for .

These factors include transportation issues, difficulty getting paid time off from work and low levels of , which is the ability to read, understand and use health information.

High levels of fatalism—the view that getting a disease is a matter of luck or fate—and low levels of health literacy among low-income Hispanics may play a strong role in whether they seek out colorectal cancer screening, according to the study, which was published in the December 2012 issue of the journal Health Affairs.

"Racial and ethnic minorities have unique challenges navigating the health care system, in some cases because they are immigrants and there are language issues, or they live in areas with high levels of uninsurance or ... few gastroenterologists," study author Jim Stimpson, director of the Center for Health Policy at the University of Nebraska Medical Center, said in a center news release.

Stimpson outlined some possible solutions, including:

  • Identifying and providing incentives for doctors to perform colonoscopies in underserved areas, which could include paying doctors more.
  • Providing patients with transportation to clinics.
  • Training other to perform colonoscopies under the supervision of a gastroenterologist via telemedicine.
" saves lives," Stimpson said. "We need to increase the number of people who get this screening, and especially focus on solutions that reduce the disparity in screening for racial or ethnic minorities."

Explore further: Racial disparities in colon cancer screening persist despite insurance, access

More information: The U.S. National Cancer Institute has more about colorectal cancer screening.

Related Stories

Racial disparities in colon cancer screening persist despite insurance, access

December 12, 2011
Public health researchers have long attributed the disparity in colonoscopy rates between whites and minorities to a lack of health insurance or access to doctors. Now, a new study suggests the reasons for the differences ...

Colorectal cancer screening rates on rise among Medicare beneficiaries due to expansion of coverage

May 3, 2011
Colorectal cancer screening rates increased for Medicare beneficiaries when coverage was expanded to average-risk individuals, but racial disparities still exist, according to researchers at The University of Texas Health ...

Study says screening accounts for much of black/white disparity in colorectal cancer

May 3, 2012
A new study finds differences in screening account for more than 40 percent of the disparity in colorectal cancer incidence and nearly 20 percent of colorectal cancer mortality between blacks and whites. Differences in stage-specific ...

Recommended for you

New approach attacks 'undruggable' cancers from the outside in

January 23, 2018
Cancer researchers have made great strides in developing targeted therapies that treat the specific genetic mutations underlying a patient's cancer. However, many of the most common cancer-causing genes are so central to ...

Study: Cells of three advanced cancers die with drug-like compounds that reverse chemo failure

January 23, 2018
Researchers at Southern Methodist University have discovered three drug-like compounds that successfully reverse chemotherapy failure in three of the most commonly aggressive cancers—ovarian, prostate and breast.

'Hijacker' drives cancer in some patients with high-risk neuroblastoma

January 23, 2018
Researchers have identified mechanisms that drive about 10 percent of high-risk neuroblastoma cases and have used a new approach to show how the cancer genome "hijacks" DNA that regulates other genes. The resulting insights ...

Enzyme inhibitor combined with chemotherapy delays glioblastoma growth

January 23, 2018
In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

Researchers identify a protein that keeps metastatic breast cancer cells dormant

January 23, 2018
A study headed by ICREA researcher Roger Gomis at the Institute for Research in Biomedicine (IRB Barcelona) has identified the genes involved in the latent asymptomatic state of breast cancer metastases. The work sheds light ...

Boosting cancer therapy with cross-dressed immune cells

January 22, 2018
Researchers at EPFL have created artificial molecules that can help the immune system to recognize and attack cancer tumors. The study is published in Nature Methods.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.